Cargando…

A Rare Presentation of Primary Central Nervous System Lymphoma in an Immunocompetent Patient

Primary central nervous system lymphoma (PCNSL) is a rare non-Hodgkin's lymphoma (NHL) that can develop in the brain, spinal cord, leptomeninges, and vitreoretinal space. The majority of cases are diffuse large B-cell lymphomas. Risk factors include immune dysfunction, prior Epstein-Barr viral...

Descripción completa

Detalles Bibliográficos
Autores principales: DeRon, Nathan, Ahmed, Maheen, Lopez, Dylan, Alobaidi, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072256/
https://www.ncbi.nlm.nih.gov/pubmed/35530884
http://dx.doi.org/10.7759/cureus.23858
_version_ 1784701020039806976
author DeRon, Nathan
Ahmed, Maheen
Lopez, Dylan
Alobaidi, Ahmed
author_facet DeRon, Nathan
Ahmed, Maheen
Lopez, Dylan
Alobaidi, Ahmed
author_sort DeRon, Nathan
collection PubMed
description Primary central nervous system lymphoma (PCNSL) is a rare non-Hodgkin's lymphoma (NHL) that can develop in the brain, spinal cord, leptomeninges, and vitreoretinal space. The majority of cases are diffuse large B-cell lymphomas. Risk factors include immune dysfunction, prior Epstein-Barr viral infection, HIV, and a family history of non-Hodgkin's lymphoma. Although the majority of the patients are immunocompromised, PCNSL is still seen in immunocompetent patients. PCNSL has a poor prognosis and a high relapse rate despite its radiosensitive and chemosensitive nature. It is important to recognize and diagnose PCNSL early to improve outcomes. We present a case of PCNSL in an immunocompetent adult with no previously known risk factors. We present a case of a 66-year-old male who presented with a 1.5-week history of right-sided headache and left-sided weakness. After being admitted for further evaluation, he underwent multiple laboratory tests and imaging studies. The CT head indicated ill-defined hypodensities in the pons and left cerebellum. CTA revealed a 1.5 cm outpouching along the medial aspect of the distal left cervical internal carotid artery at the C1-C2 level concerning a pseudoaneurysm. Neurology was consulted, and an MRI of the brain revealed equivocal brain lesions. Neurosurgery was consulted, and the patient underwent an open brain biopsy, which revealed a high likelihood of primary CNS lymphoma based on intraoperative pathology findings. CSF analysis revealed an elevated percentage of lymphocytes, including the presence of atypical lymphocytes as well as elevated oligoclonal bands. Subsequent pathology results confirmed PCNSL. The oncology service was consulted, and the patient was started on corticosteroids and methotrexate for chemotherapy as well as leucovorin. This case represents a rare presentation of PCNSL in which the patient had no known history to support an immunocompromised state. Imaging findings, in this case, were also atypical for a primary CNS lesion as they were mostly equivocal. Furthermore, imaging findings showed diffuse CNS disease rather than an obvious primary lesion as typically demonstrated in the literature. In this case, the open brain biopsy was pivotal in making a timely diagnosis and beginning disease-modifying therapy as early as possible. This case demonstrates the imperative need for clinicians to be aware of varying presentations of PCNSL and possibly consider pursuing a definitive diagnosis with biopsy when the differential includes PCNSL but remains broad after advanced imaging.
format Online
Article
Text
id pubmed-9072256
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-90722562022-05-06 A Rare Presentation of Primary Central Nervous System Lymphoma in an Immunocompetent Patient DeRon, Nathan Ahmed, Maheen Lopez, Dylan Alobaidi, Ahmed Cureus Internal Medicine Primary central nervous system lymphoma (PCNSL) is a rare non-Hodgkin's lymphoma (NHL) that can develop in the brain, spinal cord, leptomeninges, and vitreoretinal space. The majority of cases are diffuse large B-cell lymphomas. Risk factors include immune dysfunction, prior Epstein-Barr viral infection, HIV, and a family history of non-Hodgkin's lymphoma. Although the majority of the patients are immunocompromised, PCNSL is still seen in immunocompetent patients. PCNSL has a poor prognosis and a high relapse rate despite its radiosensitive and chemosensitive nature. It is important to recognize and diagnose PCNSL early to improve outcomes. We present a case of PCNSL in an immunocompetent adult with no previously known risk factors. We present a case of a 66-year-old male who presented with a 1.5-week history of right-sided headache and left-sided weakness. After being admitted for further evaluation, he underwent multiple laboratory tests and imaging studies. The CT head indicated ill-defined hypodensities in the pons and left cerebellum. CTA revealed a 1.5 cm outpouching along the medial aspect of the distal left cervical internal carotid artery at the C1-C2 level concerning a pseudoaneurysm. Neurology was consulted, and an MRI of the brain revealed equivocal brain lesions. Neurosurgery was consulted, and the patient underwent an open brain biopsy, which revealed a high likelihood of primary CNS lymphoma based on intraoperative pathology findings. CSF analysis revealed an elevated percentage of lymphocytes, including the presence of atypical lymphocytes as well as elevated oligoclonal bands. Subsequent pathology results confirmed PCNSL. The oncology service was consulted, and the patient was started on corticosteroids and methotrexate for chemotherapy as well as leucovorin. This case represents a rare presentation of PCNSL in which the patient had no known history to support an immunocompromised state. Imaging findings, in this case, were also atypical for a primary CNS lesion as they were mostly equivocal. Furthermore, imaging findings showed diffuse CNS disease rather than an obvious primary lesion as typically demonstrated in the literature. In this case, the open brain biopsy was pivotal in making a timely diagnosis and beginning disease-modifying therapy as early as possible. This case demonstrates the imperative need for clinicians to be aware of varying presentations of PCNSL and possibly consider pursuing a definitive diagnosis with biopsy when the differential includes PCNSL but remains broad after advanced imaging. Cureus 2022-04-05 /pmc/articles/PMC9072256/ /pubmed/35530884 http://dx.doi.org/10.7759/cureus.23858 Text en Copyright © 2022, DeRon et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
DeRon, Nathan
Ahmed, Maheen
Lopez, Dylan
Alobaidi, Ahmed
A Rare Presentation of Primary Central Nervous System Lymphoma in an Immunocompetent Patient
title A Rare Presentation of Primary Central Nervous System Lymphoma in an Immunocompetent Patient
title_full A Rare Presentation of Primary Central Nervous System Lymphoma in an Immunocompetent Patient
title_fullStr A Rare Presentation of Primary Central Nervous System Lymphoma in an Immunocompetent Patient
title_full_unstemmed A Rare Presentation of Primary Central Nervous System Lymphoma in an Immunocompetent Patient
title_short A Rare Presentation of Primary Central Nervous System Lymphoma in an Immunocompetent Patient
title_sort rare presentation of primary central nervous system lymphoma in an immunocompetent patient
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072256/
https://www.ncbi.nlm.nih.gov/pubmed/35530884
http://dx.doi.org/10.7759/cureus.23858
work_keys_str_mv AT deronnathan ararepresentationofprimarycentralnervoussystemlymphomainanimmunocompetentpatient
AT ahmedmaheen ararepresentationofprimarycentralnervoussystemlymphomainanimmunocompetentpatient
AT lopezdylan ararepresentationofprimarycentralnervoussystemlymphomainanimmunocompetentpatient
AT alobaidiahmed ararepresentationofprimarycentralnervoussystemlymphomainanimmunocompetentpatient
AT deronnathan rarepresentationofprimarycentralnervoussystemlymphomainanimmunocompetentpatient
AT ahmedmaheen rarepresentationofprimarycentralnervoussystemlymphomainanimmunocompetentpatient
AT lopezdylan rarepresentationofprimarycentralnervoussystemlymphomainanimmunocompetentpatient
AT alobaidiahmed rarepresentationofprimarycentralnervoussystemlymphomainanimmunocompetentpatient